Document is current
Any future updates will be listed below
-
Authors
Broderick, Ryan C.
Smith, C. Daniel
Cheverie, Joslin N.
Omelanczuk, Pablo
Lee, Arielle M. http://orcid.org/0000-0003-4475-7673
Dominguez-Profeta, Rebeca
Cubas, Robert
Jacobsen, Garth R.
Sandler, Bryan J.
Fuchs, Karl-Hermann
Horgan, Santiago
- License Information
-
More Information
Article History
Received: 1 May 2019
Accepted: 21 August 2019
First Online: 4 September 2019
Compliance with ethical standards
:
: Dr. Horgan has stock options with TORAX™ Medical Inc. Dr. Smith has a pending stock option payment from TORAX™ Medical Inc. Dr. Jacobsen has two grants with TORAX™ Medical Inc, the first for <i>The CALIBER Study: Randomized Controlled Trial of LINX versus Double</i>-<i>Dose Proton Pump Inhibitor Therapy for Reflux Disease,</i> and the second for <i>A Post</i>-<i>Approval Study of the LINX</i> ® <i>Reflux management system.</i> Drs. Broderick, Cheverie, Omelanczuk, Lee, Dominguez-Profeta, Cubas, Sandler, and Fuchs have no conflicts of interest or financial ties to disclose.
